In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice

(2012) E. Bart Tarbet et al.   ANTIVIRAL RESEARCH

Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia

(2012) A. C. Hurt et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses

(2012) Jack T. Nguyen et al.   PLoS One

Systematic review of influenza resistance to the neuraminidase inhibitors

(2011) Kristian Thorlund et al.   BMC INFECTIOUS DISEASES

Cluster of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital Ward among Immunocompromised Patients—North Carolina, 2009

(2011) Luke F. Chen et al.   JOURNAL OF INFECTIOUS DISEASES

Reassortment and Mutations Associated with Emergence and Spread of Oseltamivir-Resistant Seasonal Influenza A/H1N1 Viruses in 2005–2009

(2011) Ji-Rong Yang et al.   PLoS One

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

(2011) Justin D. Hoopes et al.   PLoS One

In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses

(2010) K. Sleeman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro

(2010) Larisa V Gubareva et al.   ANTIVIRAL THERAPY

Targeting pandemic influenza: a primer on influenza antivirals and drug resistance

(2010) R. B. Moss et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance

(2010) J. D. Bloom et al.   SCIENCE

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

(2010) Xavier Duval et al.   PLOS MEDICINE

Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

(2009) J. T. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice

(2009) D. F. Smee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

(2009) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

Influenza Virus Resistance to Antiviral Agents: A Plea for Rational Use

(2009) Gregory A. Poland et al.   CLINICAL INFECTIOUS DISEASES

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

(2009) Nicolas Collin et al.   VACCINE

Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice

(2008) N. A. Ilyushina et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY